Genetics and molecular pathogenesis of the myotonic dystrophies

被引:27
|
作者
Day J.W. [1 ]
Ranum L.P.W. [1 ]
机构
[1] Department of Neurology, Institute of Human Genetics, Univ. of Minnesota Sch. of Medicine, Minneapolis, MN 55455
关键词
Repeat Expansion; Myotonic Dystrophy; Myotonic Dystrophy Type; Dystrophia Myotonica Protein Kinase; Cellular Nucleic Acid Binding Protein;
D O I
10.1007/s11910-005-0024-1
中图分类号
学科分类号
摘要
Pathogenic repeat expansions were initially identified as causing either a loss of gene product, such as in fragile X mental retardation, or an expansion of a polyglutamine region of a protein, as was first shown in spinobulbar muscular atrophy (Kennedy's disease). The pathogenic effect of the repeat expansion in myotonic dystrophy type 1, however, has been controversial because it does not encode a protein but nonetheless results in a highly penetrant dominant disease. Clinical and molecular characterization of myotonic dystrophy types 1 and 2 have now demonstrated a novel disease mechanism involving pathogenic effects of repeat expansions that are expressed in RNA but are not translated into protein. Copyright © 2005 by Current Science Inc.
引用
收藏
页码:55 / 60
页数:5
相关论文
共 50 条
  • [21] Motor unit number estimation by MScanFit in myotonic dystrophies
    Schneider, Christian
    Svacina, Martin K. R.
    Kohle, Felix
    Sprenger-Svacina, Alina
    Fink, Gereon R.
    Lehmann, Helmar C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 451
  • [22] New developments in myotonic dystrophies from a multisystemic perspective
    Montagnese, Federica
    Schoser, Benedikt
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (05) : 738 - 747
  • [23] Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies
    Koscianska, Edyta
    Kozlowska, Emilia
    Fiszer, Agnieszka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [24] Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
    Ranum L.P.
    Day J.W.
    Current Neurology and Neuroscience Reports, 2002, 2 (5) : 465 - 470
  • [25] Myotonic Dystrophies: Stateofthe Art of New Therapeutic Developments for the CNS
    Gourdon, Genevieve
    Meola, Giovanni
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2017, 11
  • [26] A Greek National Cross-Sectional Study on Myotonic Dystrophies
    Papadimas, Georgios K.
    Papadopoulos, Constantinos
    Kekou, Kyriaki
    Kartanou, Chrisoula
    Kladi, Athina
    Nitsa, Evangelia
    Sofocleous, Christalena
    Tsanou, Evangelia
    Sarmas, Ioannis
    Kaninia, Stefania
    Chroni, Elisabeth
    Tsivgoulis, Georgios
    Kimiskidis, Vasilios
    Arnaoutoglou, Marianthi
    Stefanis, Leonidas
    Panas, Marios
    Koutsis, Georgios
    Karadima, Georgia
    Traeger-Synodinos, Joanne
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [27] Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies
    Espinosa-Espinosa, Jorge
    Gonzalez-Barriga, Anchel
    Lopez-Castel, Arturo
    Artero, Ruben
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [28] Educational and Professional Qualifications of Adults With Myotonic Dystrophies - A Misleading Perception by the Myopathic Face?
    Stahl, K.
    Wenninger, S.
    Schueller, A.
    Montagnese, F.
    Schoser, B.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2016, 84 (04) : 211 - 216
  • [29] Association of peripheral neuropathy with sleep- related breathing disorders in myotonic dystrophies
    Banach, Marta
    Antczak, Jakub
    Rola, Rafal
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 133 - 140
  • [30] Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2
    Romeo, Vincenzo
    Pegoraro, E.
    Ferrati, C.
    Squarzanti, F.
    Soraru, G.
    Palmieri, A.
    Zucchetta, P.
    Antunovic, L.
    Bonifazi, E.
    Novelli, G.
    Trevisan, C. P.
    Ermani, M.
    Manara, R.
    Angelini, C.
    JOURNAL OF NEUROLOGY, 2010, 257 (08) : 1246 - 1255